The present invention relates to compositions and methods for cancer
diagnostics and therapeutics, including but not limited to, RKIP cancer
markers and RKIP pathway modulators. In particular, the present invention
provides compositions and methods of using RKIP in the diagnosis and
treatment of prostate cancers.